Skip to main content
Top
Published in: European Journal of Plastic Surgery 6/2014

01-06-2014 | Original Paper

Is dermatome shaving a potential treatment for actinic keratosis in organ transplant recipients? A cross-sectional study

Authors: Ulrik Kjerkegaard, Morten Bischoff-Mikkelsen, Tine Engberg Damsgaard, Torben Steiniche, Birgitte Stausbøl-Grøn, Lars Bjørn Stolle

Published in: European Journal of Plastic Surgery | Issue 6/2014

Login to get access

Abstract

Background

Non-melanoma skin cancer (NMSC) is correlated with high morbidity and mortality in solid-organ transplant recipients (OTR) and it appears after a mean interval of 8 to 10 years. Prophylactic treatments are still required to prevent the development of NMSC. This study aims to investigate whether dermatome shaving reduced the occurrence of keratotic skin lesions in OTRs.

Methods

A retrospective study was conducted. One thousand and twenty-four patients who had a split-thickness skin graft due to NMSC excision were identified in the Central Denmark Region and the Region of Southern Denmark between 1996 and 2011. Eleven of these patients were OTRs at the time of split-thickness skin grafting and were included in the study. The patients were examined for keratotic skin lesions, representing suspected premalignant lesions, on the donor area of the split-thickness skin graft, recipient area and two corresponding control areas. Epidemiological and medical parameters for each patient were registered via medical records and through patient interviews.

Results

The average time between split-thickness skin grafting and clinical examination was 6.2 years (1.1–16.8). The occurrence of keratotic skin lesions were lower in the donor area compared to both of the control areas (Wilcoxon matched-pairs signed-rank test, p = 0.024, respectively, p = 0.019).

Conclusions

Dermatome shaving reduced the occurrence of keratotic skin lesions in OTRs and might prevent the development of field cancerization and NMSC.
Level of Evidence: Level III, therapeutic study.
Literature
1.
go back to reference Ulrich C, Kanitakis J, Stockfleth E, Euvrard S (2008) Skin cancer in organ transplant recipients—where do we stand today? Am J Transplant 8:2192–2198PubMedCrossRef Ulrich C, Kanitakis J, Stockfleth E, Euvrard S (2008) Skin cancer in organ transplant recipients—where do we stand today? Am J Transplant 8:2192–2198PubMedCrossRef
2.
go back to reference Euvrard S, Kanitakis J, Pouteil-Noble C et al (1995) Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 33:222–229PubMedCrossRef Euvrard S, Kanitakis J, Pouteil-Noble C et al (1995) Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 33:222–229PubMedCrossRef
3.
go back to reference Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691PubMedCrossRef Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691PubMedCrossRef
4.
go back to reference Tessari G, Girolomoni G (2012) Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 38(10):1622–1630PubMedCrossRef Tessari G, Girolomoni G (2012) Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 38(10):1622–1630PubMedCrossRef
5.
go back to reference Bavinck JN, De Boer A, Vermeer BJ et al (1993) Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 129:242–249PubMedCrossRef Bavinck JN, De Boer A, Vermeer BJ et al (1993) Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 129:242–249PubMedCrossRef
6.
go back to reference Bouwes Bavinck JN, Euvrard S, Naldi L et al (2007) Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127:1647–1656PubMedCentralPubMed Bouwes Bavinck JN, Euvrard S, Naldi L et al (2007) Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127:1647–1656PubMedCentralPubMed
7.
go back to reference Lindelof B, Sigurgeirsson B, Gabel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513–519PubMedCrossRef Lindelof B, Sigurgeirsson B, Gabel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513–519PubMedCrossRef
8.
go back to reference Ulrich C, Jurgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78–84PubMedCrossRef Ulrich C, Jurgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78–84PubMedCrossRef
10.
go back to reference EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant 17(Suppl 4):31–36 EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant 17(Suppl 4):31–36
11.
go back to reference Boehnke K, Falkowska-Hansen B, Stark HJ, Boukamp P (2012) Stem cells of the human epidermis and their niche: composition and function in epidermal regeneration and carcinogenesis. Carcinogenesis 33:1247–1258PubMedCrossRef Boehnke K, Falkowska-Hansen B, Stark HJ, Boukamp P (2012) Stem cells of the human epidermis and their niche: composition and function in epidermal regeneration and carcinogenesis. Carcinogenesis 33:1247–1258PubMedCrossRef
12.
go back to reference Kaminaka C, Yamamoto Y, Yonei N, Kishioka A, Kondo T, Furukawa F (2009) Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations. J Am Acad Dermatol 60(4):615–625PubMedCrossRef Kaminaka C, Yamamoto Y, Yonei N, Kishioka A, Kondo T, Furukawa F (2009) Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations. J Am Acad Dermatol 60(4):615–625PubMedCrossRef
13.
go back to reference Stuzin JM (1998) Phenol peeling and the history of phenol peeling. Clin Plast Surg 25(1):1–19PubMed Stuzin JM (1998) Phenol peeling and the history of phenol peeling. Clin Plast Surg 25(1):1–19PubMed
14.
go back to reference Katz TM, Goldberg LH, Marquez D et al (2011) Nonablative fractional photothermolysis for facial actinic keratoses: 6-month follow-up with histologic evaluation. J Am Acad Dermatol 65(2):349–356PubMedCrossRef Katz TM, Goldberg LH, Marquez D et al (2011) Nonablative fractional photothermolysis for facial actinic keratoses: 6-month follow-up with histologic evaluation. J Am Acad Dermatol 65(2):349–356PubMedCrossRef
15.
go back to reference Togsverd-Bo K, Paasch U, Haak CS, Haedersdal M (2012) Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions. Lasers Med Sci 27(3):675–679PubMedCrossRef Togsverd-Bo K, Paasch U, Haak CS, Haedersdal M (2012) Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions. Lasers Med Sci 27(3):675–679PubMedCrossRef
16.
go back to reference Epstein EH Jr, Bwik PG, Cohen IK, Deckers P (1972) Dermatome shaving in the treatment of xeroderma pigmentosum. Arch Dermatol 105:589–590PubMedCrossRef Epstein EH Jr, Bwik PG, Cohen IK, Deckers P (1972) Dermatome shaving in the treatment of xeroderma pigmentosum. Arch Dermatol 105:589–590PubMedCrossRef
17.
go back to reference Momsen OH, Kiil J (1993) Dermatome shaving of psoriasis. Seven years experience in 112 patients. Scand J Plast Reconstr Surg Hand Surg 27:143–147PubMedCrossRef Momsen OH, Kiil J (1993) Dermatome shaving of psoriasis. Seven years experience in 112 patients. Scand J Plast Reconstr Surg Hand Surg 27:143–147PubMedCrossRef
18.
go back to reference Levy V, Lindon C, Zheng Y, Harfe BD, Morgan BA (2007) Epidermal stem cells arise from the hair follicle after wounding. FASEB J 21:1358–1366PubMedCrossRef Levy V, Lindon C, Zheng Y, Harfe BD, Morgan BA (2007) Epidermal stem cells arise from the hair follicle after wounding. FASEB J 21:1358–1366PubMedCrossRef
19.
go back to reference de Gruijl FR, Rebel H (2008) Early events in UV carcinogenesis–DNA damage, target cells and mutant p53 foci. Photochem Photobiol 84:382–387PubMedCrossRef de Gruijl FR, Rebel H (2008) Early events in UV carcinogenesis–DNA damage, target cells and mutant p53 foci. Photochem Photobiol 84:382–387PubMedCrossRef
20.
go back to reference Nishigori C, Hattori Y, Toyokuni S (2004) Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 6:561–570PubMedCrossRef Nishigori C, Hattori Y, Toyokuni S (2004) Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 6:561–570PubMedCrossRef
21.
go back to reference Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM (2004) The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A 101:4954–4959PubMedCentralPubMedCrossRef Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM (2004) The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A 101:4954–4959PubMedCentralPubMedCrossRef
22.
go back to reference Runger TM, Kappes UP (2008) Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 24:2–10PubMedCrossRef Runger TM, Kappes UP (2008) Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 24:2–10PubMedCrossRef
23.
go back to reference España A, Martínez-González MA, García-Granero M, Sánchez-Carpintero I, Rábago G, Herreros J (2000) A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 115(6):1158–1160PubMedCrossRef España A, Martínez-González MA, García-Granero M, Sánchez-Carpintero I, Rábago G, Herreros J (2000) A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 115(6):1158–1160PubMedCrossRef
Metadata
Title
Is dermatome shaving a potential treatment for actinic keratosis in organ transplant recipients? A cross-sectional study
Authors
Ulrik Kjerkegaard
Morten Bischoff-Mikkelsen
Tine Engberg Damsgaard
Torben Steiniche
Birgitte Stausbøl-Grøn
Lars Bjørn Stolle
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Plastic Surgery / Issue 6/2014
Print ISSN: 0930-343X
Electronic ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-014-0945-5

Other articles of this Issue 6/2014

European Journal of Plastic Surgery 6/2014 Go to the issue